PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
Reinhard ReussDepartment of Neurology, BKH Bayreuth, Bayreuth, GermanyAbstract: Current standard immunomodulatory therapy with interferons (IFNs) for relapsing–remitting multiple sclerosis (MS) exhibits proven, but limited, efficacy and increased side effects due to the need of frequent ap...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-05-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/pegylated-interferon-beta-1a-in-the-treatment-of-multiple-sclerosis-nd-a13194 |